Early signatures of bleeding and mortality in patients on left ventricular assist device support: novel methods for personalized risk-stratification

References

• Adatya, S. and Bennett, M.K., 2015. Anticoagulation management in mechanical circulatory support. Journal of thoracic disease, 7, 2129–2138.
   PubMed Web of Science ®Google Scholar
• Allen, J.G., et al., 2010. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. Journal of heart and lung transplantation, 29 (3), 278–285.
   PubMed Web of Science ®Google Scholar
• Bartoli, C.R., et al., 2015. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage. Journal of thoracic and cardiovascular surgery, 149 (1), 281–289.
   PubMed Web of Science ®Google Scholar
• Blitz, A., 2014. Pump thrombosis—a riddle wrapped in a mystery inside an enigma. Annals of cardiothoracic surgery, 3 (5), 450–471.
   PubMedGoogle Scholar
• Boyle, A.J., et al., 2009. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. The journal of heart and lung transplantation, 28 (9), 881–887.
   PubMed Web of Science ®Google Scholar
• Crow, S., et al., 2010a. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Annals of thoracic surgery, 90 (4), 1263–1269, discussion 1269.
   PubMed Web of Science ®Google Scholar
• Crow, S., et al., 2010b. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO journal, 56 (5), 441–445.
   PubMed Web of Science ®Google Scholar
• Geisen, U., et al., 2008. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. European journal of cardio-thoracic surgery, 33 (4), 679–684.
   PubMed Web of Science ®Google Scholar
• Harvey, L., Holley, C.T., and John, R., 2014. Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Annals of cardiothoracic surgery, 3, 475–479.
   PubMedGoogle Scholar
• Heilmann, C., et al., 2010. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Thrombosis and haemostasis, 103 (5), 962–967.
   PubMed Web of Science ®Google Scholar
• Jilma-Stohlawetz, P., et al., 2016. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent. Thrombosis research, 137, 196–201.
   PubMed Web of Science ®Google Scholar
• Kilic, A. and Kiernan, M.S., 2017. Common clinical dilemmas in left ventricular assist device therapy: a glimpse into current trends. VAD journal, 3, 1–17.
   Google Scholar
• Krabatsch, T., et al., 2017. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial. Journal of cardiothoracic surgery, 12, 23.
   PubMed Web of Science ®Google Scholar
• Lefrancais, E., et al., 2017. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature, 544, 105–109.
   PubMed Web of Science ®Google Scholar
• Levy, D., et al., 2002. Long-term trends in the incidence of and survival with heart failure. New England journal of medicine, 347 (18), 1397–1402.
   PubMed Web of Science ®Google Scholar
• Maltais, S., et al., 2017. PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study. Journal of heart and lung transplantation, 36 (1), 1–12.
   PubMed Web of Science ®Google Scholar
• Mehra, M.R., et al., 2017. A fully magnetically levitated circulatory pump for advanced heart failure. New England journal of medicine, 376 (5), 440–450.
   PubMed Web of Science ®Google Scholar
• Meyer, A.L., et al., 2010. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circulation: heart failure, 3 (6), 675–681.
   PubMed Web of Science ®Google Scholar
• Miller, L.W., Guglin, M., and Rogers, J., 2013. Cost of ventricular assist devices: can we afford the progress? Circulation, 127 (6), 743–748.
   PubMed Web of Science ®Google Scholar
• Overgaard, C.B., et al., 2008. Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. American heart journal, 156 (1), 120–124.
   PubMed Web of Science ®Google Scholar
• Patel, S.R., et al., 2018. Cessation of continuous flow left ventricular assist device-related gastrointestinal bleeding after heart transplantation. ASAIO journal, 64 (2), 191–195.
   PubMed Web of Science ®Google Scholar
• Puehler, T., et al., 2014. Mechanical circulatory support devices as destination therapy-current evidence. Annals of cardiothoracic surgery, 3, 513–524.
   PubMedGoogle Scholar
• Raphael, C.E., et al., 2016. Effect of preprocedural thrombocytopenia on prognosis after percutaneous coronary intervention. Mayo clinic proceedings, 91 (8), 1035–1044.
   PubMed Web of Science ®Google Scholar
• Schroder, J.N. and Milano, C.A., 2017. A tale of two centrifugal left ventricular assist devices. The journal of thoracic and cardiovascular surgery, 154 (3), 850–852.
   PubMed Web of Science ®Google Scholar
• Sexton, T.R., et al., 2016. Thromboinflammatory response and predictors of outcomes in patients undergoing transcatheter aortic valve replacement. Journal of thrombosis and thrombolysis, 41 (3), 384–393.
   PubMed Web of Science ®Google Scholar
• Shah, P., et al., 2017. Bleeding and thrombosis associated with ventricular assist device therapy. The journal of heart and lung transplantation, 36 (11), 1164–1173.
   PubMed Web of Science ®Google Scholar
• Slaughter, M.S., et al., 2009. Advanced heart failure treated with continuous-flow left ventricular assist device. New England journal of medicine, 361 (23), 2241–2251.
   PubMed Web of Science ®Google Scholar
• Tarzia, V., et al., 2014. Hemorrhage and thrombosis with different LVAD technologies: a matter of flow? Annals of cardiothoracic surgery, 3 (6), 582–584.
   PubMedGoogle Scholar
• Tchantchaleishvili, V., et al., 2014. Evaluation and treatment of pump thrombosis and hemolysis. Annals of cardiothoracic surgery, 3 (5), 490–495.
   PubMedGoogle Scholar
• Uriel, N., et al., 2010. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. Journal of the American college of cardiology, 56 (15), 1207–1213.
   PubMed Web of Science ®Google Scholar
• Writing Group, M., et al., 2016. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation, 133, e38–e360.
   PubMed Web of Science ®Google Scholar
• Yuan, N., et al., 2012. The spectrum of complications following left ventricular assist device placement. Journal of cardiac surgery, 27 (5), 630–638.
   PubMed Web of Science ®Google Scholar